Data as of Mar 06
| +0.13 / +1.07%|
The 3 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 38.00 and a low estimate of 20.00. The median estimate represents a +144.10% increase from the last price of 12.29.
The current consensus among 3 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.